The ALA201HIS mutant CtBP2 more potently ameliorated diabetes and hepatic steatosis than wild-type CtBP2 without inducing any changes in body weights (Fig. 8d, e and Supplementary Fig. 9c). Here, CTBP2 is linked to fatty liver disease.